High CS promoted NOX2/Calcium–calmodulin (CaM)‐dependent protein kinase II (CaMKII)/ Extracellular signal‐regulated protein kinase 1/2 (ERK1/2) axis activation induces VILI in vivo and endothelial dysfunction in vitro. Here, MAPK3 is linked to endothelial dysfunction.